The insulin prepared through genetic engineering by an American company named "Eli Lilly" in 1983 is called
In 1983, Eli Lilly an American company prepared two DNA sequences
corresponding to A and B, chains of human insulin and introduced them
in plasmids of E. coli to produce insulin chains. Chains A and B were
produced separately, extracted and combined by creating disulfide bonds
to form human insulin also known as humulin